Connection

Payam Tabarsi to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Payam Tabarsi has written about Antibodies, Monoclonal, Humanized.
Payam Tabarsi
Connection Strength
0.543
Antibodies, Monoclonal, Humanized
  1. Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. Int Immunopharmacol. 2020 Dec; 89(Pt B):107102.
    View in: PubMed
    Score: 0.183
  2. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869.
    View in: PubMed
    Score: 0.181
  3. Tocilizumab administration in a refractory case of COVID-19. Int J Antimicrob Agents. 2020 Aug; 56(2):106043.
    View in: PubMed
    Score: 0.179
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.